Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 15/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 13/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | LGMN | Q99538 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.38 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7143760 | 0.87 | HDAC2 (0.44) | HDAC2HDAC1HDAC3RAB9AALDH1A1 | |
| SCHEMBL7704803 | 0.85 | ALDH1A1 (0.41) | RAB9ALGMNALDH1A1LMNANPC1 | |
| SCHEMBL7138095 | 0.72 | ALDH1A1 (0.37) | HDAC2HDAC1RAB9ALGMNALDH1A1 | |
| SCHEMBL7139674 | 0.72 | ALDH1A1 (0.44) | RAB9AALDH1A1LMNA | |
| SCHEMBL7707281 | 0.70 | SMN1; SMN2 (0.45) | RAB9AALDH1A1LMNANPC1 | |
| SCHEMBL6608182 | 0.69 | TSHR (0.48) | HDAC2HDAC1HDAC3RAB9AALDH1A1 | |
| SCHEMBL7139652 | 0.67 | HDAC2 (0.46) | HDAC2HDAC1HDAC3 | |
| SCHEMBL7145400 | 0.67 | HDAC2 (0.43) | HDAC2HDAC1HDAC3 | |
| SCHEMBL13737740 | 0.65 | HDAC2 (0.71) | HDAC2HDAC1HDAC3 | |
| SCHEMBL13735115 | 0.65 | HDAC1 (0.55) | HDAC2HDAC1HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1224174-A2 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001029011-A2 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-04-26 | — | — | WO | disclosed |